Alvotech reports financial results for full year 2022 and provides business update

Reykjavik, iceland (march 1, 2023) — alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for full year 2022 and provided a summary of recent corporate highlights.
ALVO Ratings Summary
ALVO Quant Ranking